Australia's CSL's vaccine unit to collaborate on flu vaccines with Saudi Arabia
30/10/2025 06:12
Oct 30 (Reuters) - Biotech firm CSL CSL.AX said on Thursday its vaccine arm, CSL Seqirus and Vaccine Industrial Company, had inked a deal with Saudi Arabia's Health Ministry to localize manufacturing of cell-based seasonal and pandemic influenza vaccines. The deal comes a few days later after Australia's CSL said it was no longer targeting to complete the spin off of Seqirus in fiscal 2026 amid heightened volatility in the U.S. vaccine markets. (Reporting by Nichiket Sunil in Bengaluru; Editing by Rashmi Aich) ((Nichiket.Sunil@thomsonreuters.com))
Recent news on Csl
See all newsEU Commission opens antitrust probe into Sanofi's flu vaccine campaign (updated)
EU Commission opens antitrust probe into Sanofi's flu vaccine campaign
Analysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
US military requires flu vaccine for some after outbreak in Texas training center
Corrected: BUZZ-Australian healthcare stocks hit a six-week high, acting as a primary hedge on ASX